Oxidative stress and mitochondrial disease

Oxidative Stress, Disease and Cancer

Volumn , Issue , 2006, Pages 649-672

  Lu, Ching You ^a   Lee, Cheng Feng ^a   Ma, Yi Shing ^a   Liu, Chun Yi ^a   Wei, Chia Yu ^a   Chen, Yin Chiu ^a   Wu, Shi Bei ^a   Wei, Yau Huei ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84967355742     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1142/9781860948046_0021     Document Type: Chapter

References (83)

1. Chance B, Sies H, Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol. Rev. 59: 527-605 (1979).
2. Hockenbery DM, Oltvai ZN, Yin XM, Milliman C, Korsmeyer SJ. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75: 241-251 (1993).
3. Allen RG, Balin AK. Oxidative influence on development and differentiation: an overview of a free radical theory of development. Free Radic. Biol. Med. 6: 631-661 (1989).
4. Fraga CG, Shigenaga MK, Park JW, Degan P, Ames BN. Oxidative damage to DNA during aging: 8-hydroxy-2′-deoxyguanosine in rat organ DNA and urine. Proc. Natl. Acad. Sci. USA 87: 4533-4537 (1990).
5. Stadtman ER. Protein oxidation and aging. Science 257: 1220-1224 (1992).
6. Rikans LE, Hornbrook KR. Lipid peroxidation, antioxidant protection and aging. Biochim. Biophys. Acta 1362: 116-127 (1997).
7. 2), superoxide dismutases, and related matters. J. Biol. Chem. 272: 18515-18517 (1997).
8. Halliwell B. Free Radicals in Biology and Medicine, 3rd edn. Clarendon Press, Oxford, 1999.
9. Turrens JF. Superoxide production by the mitochondrial respiratory chain. Biosci. Rep. 17: 3-8 (1997).
10. Richter C, Gogvadze V, Laffranchi R, Schlapbach R, Schweizer M, Suter M, Walter P, Yaffee M. Oxidants in mitochondria: from physiology to diseases. Biochim. Biophys. Acta 1271: 67-74 (1995).
11. Lu CY, Wang EK, Lee HC, Tsay HJ, Wei YH, Increased expression of manganese-superoxide dismutase in fibroblasts of patients with CPEO syndrome. Mol. Genet. Metab. 80: 321-329 (2003).
12. Yen MY, Kao SH, Wang AG, Wei YH. Increased 8-hydroxy-2′- deoxyguanosine in leukocyte DNA in Leber’s hereditary optic neuropathy. Invest. Ophthalmol. Vis. Sci. 45: 1688-1691 (2004).
13. Nohl H, Hegner D. Do mitochondria produce oxygen radicals in vivo? Eur. J. Biochem. 82: 563-567 (1978).
14. Yakes FM, van Houten B. Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc. Natl. Acad. Sci. USA 94: 514-519 (1997).
15. Wallace DC, Ye JH, Neckelmann SN, Singh G, Webster KA, Greenberg BD. Sequence analysis of cDNAs for the human and bovine ATP synthase beta subunit: mitochondrial DNA genes sustain seventeen times more mutations. Curr. Genet. 12: 81-90 (1987).
16. Wallace DC. Mitochondrial diseases in man and mouse. Science 283: 1482-1488 (1999).
17. Schon EA, Manfredi G. Neuronal degeneration and mitochondrial dysfunction. J. Clin. Invest. 111: 303-312 (2003).
18. Wei YH, Lee HC. Mitochondrial DNA mutations and oxidative stress in mitochondrial diseases. Adv. Clin. Chem. 37: 83-128 (2003).
19. Zeviani M, Spinazzola A. Mitochondrial disorders. Curr. Neurol. Neurosci. Rep. 3: 423-432 (2003).
20. Morgan-Hughes JA, Hanna MG. Mitochondrial encephalomyopathies: the enigma of genotype versus phenotype. Biochim. Biophys. Acta 1410: 125-145 (1999).
21. Melov S, Coskun P, Patel M, Tuinstra R, Cottrell B, Jun AS, Zastawny TH, Dizdaroglu M, Goodman SI, Huang TT, Miziorko H, Epstein CJ, Wallace DC. Mitochondrial disease in superoxide dismutase 2 mutant mice. Proc. Natl. Acad. Sci. USA 96: 846-851 (1999).
22. Pang CY, Lee HC, Wei YH. Enhanced oxidative damage inhuman cells harboring A3243G mutation of mitochondrial DNA: implication of oxidative stress in the pathogenesis of mitochondrial diabetes. Diabetes Res. Clin. Pract. 54 (Suppl 2): S45-S56 (2001).
23. Robinson BH. Human complex I deficiency: clinical spectrum and involvement of oxygen free radicals in the pathogenicity of the defect. Biochim. Biophys. Acta 1364: 271-286 (1998).
24. Luo X, Pitkanen S, Kassovska-Bratinova S, Robinson BH, Lehotay DC. Excessive formation of hydroxyl radicals and aldehydic lipid peroxidation products in cultured skin fibroblasts from patients with complex I deficiency. J. Clin. Invest. 99: 2877-2882 (1997).
25. Ihara Y, Hayabara T, Namba R, Nobukuni K, Mori A. Free radical, lipid peroxide and antioxidant in mitochondrial encephalomyopathy. Rinsho Shinkeigaku 34: 593-595 (1994).
26. Barrientos A, Moraes CT. Titrating the effects of mitochondrial complex I impairment in the cell physiology. J. Biol. Chem. 274: 16188-16197 (1999).
27. Piccolo G, Banfi P, Azan G, Rizzuto R, Bisson R, Sandona D, Bellomo G. Biological markers of oxidative stress in mitochondrial myopathies with progressive external ophthalmoplegia. J. Neurol. Sci. 105: 57-60 (1991).
28. Pitkänen S, Robinson BH. Mitochondrial complex I deficiency leads to increased production of superoxide radicals and induction of superoxide dismutase. J. Clin. Invest. 98: 345-351 (1996).
29. Ohkoshi N, Mizusawa H, Shiraiwa N, Shoji S, Harada K, Yoshizawa K. Superoxide dismutases of muscle in mitochondrial encephalomyopathies. Muscle Nerve 18: 1265-1271 (1995).
30. Brambilla L, Cairo G, Sestili P, O’Donnel V, Azzi A, Cantoni O. Mitochondrial respiratory chain deficiency leads to overexpression of antioxidant enzymes. FEBS Lett. 418: 247-250 (1997).
31. Rusanen H, Majamaa K, Hassinen IE. Increased activities of antioxidant enzymes and decreased ATP concentration in cultured myoblasts with the 3243A→G mutation in mitochondrial DNA. Biochim. Biophys. Acta 1500: 10-16 (2000).
32. Mitsui T, Kawai H, Nagasawa M, Kunishige M, Akaike M, Kimura Y, Saito S. Oxidative damage to skeletal muscle DNA from patients with mitochondrial encephalomyopathies. J. Neurol. Sci. 139: 111-116 (1996).
33. Filosto M, Tonin P, Vattemi G, Spagnolo M, Rizzuto N, Tomelleri G. Antioxidant agents have a different expression pattern in muscle fibers of patients with mitochondrial diseases. Acta Neuropathol. 103: 215-220 (2002).
34. Kunishige M, Mitsui T, Akaike M, Kawajiri M, Shono M, Kawai H, Matsumoto T. Overexpressions of myoglobin and antioxidant enzymes in ragged-red fibers of skeletal muscle from patients with mitochondrial encephalomyopathy. Muscle Nerve 28: 484-492 (2003).
35. Orr WC, Mockett RJ, Benes JJ, Sohal RS. Effects of overexpression of copper-zinc and manganese superoxide dismutases, catalase, and thioredoxin reductase genes on longevity in Drosophila melanogaster. J. Biol. Chem. 278: 26418-26422 (2003).
36. Chen Q, Ames BN. Senescence-like growth arrest induced by hydrogen peroxide in human diploid fibroblast F65 cells. Proc. Natl. Acad. Sci. USA 91: 4130-4134 (1994).
37. Amstad P, Moret R, Cerutti P. Glutathione peroxidase compensates for the hypersensitivity of Cu,Zn-superoxide dismutase overproducers to oxidant stress. J. Biol. Chem. 269: 1606-1609 (1994).
38. Ceballos I, Delabar JM, Nicole A, Lynch RE, Hallewell RA, Kamoun P, Sinet PM. Expression of transfected human Cu,Zn superoxide dismutase gene in mouse L cells and NS20Y neuroblastomacells induces enhancement of glutathione peroxidase activity. Biochim. Biophys. Acta 949: 58-64 (1988).
39. de Haan JB, Cristiano F, Iannello R, Bladier C, Kelner MJ, Kola I. Elevation in the ratio of Cu/Zn-superoxide dismutase to glutathione peroxidase activity induces features of cellular senescence and this effect is mediated by hydrogen peroxide. Hum. Mol. Genet. 5: 283-292 (1996).
40. Li N, Oberley TD, Oberley LW, Zhong W. Inhibition of cell growth in NIH/3T3 fibroblasts by overexpression of manganese superoxide dismutase: mechanistic studies. J. Cell. Physiol. 175: 359-369 (1998).
41. Wenk J, Brenneisen P, Wlaschek M, Poswig A, Briviba K, Oberley TD, Scharffetter-Kochanek K. Stable overexpression of manganese superoxide dismutase in mitochondria identifies hydrogen peroxide as a major oxidant in the AP-1-mediated induction of matrix-degrading metalloprotease-1. J. Biol. Chem. 274: 25869-25876 (1999).
42. Li Y, et al. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat. Genet. 11: 376-381 (1995).
43. Williams MD, van Remmen H, Conrad CC, Huang TT, Epstein CJ, Richardson A. Increased oxidative damage is correlated to altered mitochondrial function in heterozygous manganese superoxide dismutase knockout mice. J. Biol. Chem. 273: 28510-28515 (1998).
44. Melov S, Schneider JA, Day BJ, Hinerfeld D, Coskun P, Mirra SS, Crapo JD, Wallace DC. A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase. Nat. Genet. 18: 159-163 (1998).
45. Ho Y-S, Magnetat J-L, Bronson RT, Cao J, Gargano M, Sugawara M, Funk CD. Mice deficient in cellular glutathione peroxidase develop normally and show no increased sensitivity to hyperoxia. J. Biol. Chem. 272: 16644-16651 (1997).
46. Cheng WH, Ho YS, Ross DA, Valentine BA, Combs GF, Lei XG. Cellular glutathione peroxidase knockout mice express normal levels of seleniumdependent plasma and phospholipid hydroperoxide glutathione peroxidases in various tissues. J. Nutr. 127: 1445-1450 (1997).
47. de Haan JB, Bladier C, Griffiths P, Kelner M, O’Shea RD, Cheung NS, Bronson RT, Silvestro MJ, Wild S, Zheng SS, Beart PM, Hertzog PJ, Kola I. Mice with a homozygous null mutation for the most abundant glutathione peroxidase, Gpx1, show increased susceptibility to the oxidative stress-inducing agents paraquat and hydrogen peroxide. J. Biol. Chem. 273: 22528-22536 (1998).
48. 2-mediated cell death. Free Radic. Biol. Med. 36, 53-64 (2004).
49. Esposito LA, Melov S, Panov A, Cottrell BA, Wallace DC. Mitochondrial disease in mouse results in increased oxidative stress. Proc. Natl. Acad. Sci. USA 96: 4820-4825 (1999).
50. 2) increases the steady-state mRNA levels of collagenase/MMP-1 in human dermal fibroblasts. Free Radic. Biol. Med. 22: 515-524 (1997).
51. Wallace DC. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Ann. Rev. Genet., Epub ahead of print (2005).
52. Slupphaug G, Kavli B, Krokan HE. The interacting pathways for prevention and repair of oxidative DNA damage. Mutat. Res. 531: 231-251 (2003).
53. Grollman AP, Moriya M. Mutagenesis by 8-oxoguanine: an enemy within. Trends Genet. 9: 246-249 (1993).
54. Takao M, Aburatani H, Kobayashi K, Yasui A. Mitochondrial targeting of human DNA glycosylases for repair of oxidative DNA damage. Nucleic Acids Res. 26: 2917-2922.
55. Tomkinson AE, Bonk RT, Linn S. Mitochondrial endonuclease activities specific for apurinic/apyrimidinic sites in DNA from mouse cells. J. Biol. Chem. 263: 12532-12537 (1988).
56. Croteau DL, ap Rhys CM, Hudson EK, Dianov GL, Hansford RG, Bohr VA. An oxidative damage-specific endonuclease from rat liver mitochondria. J. Biol. Chem. 272: 27338-27344 (1997).
57. Souza-Pinto NC, Croteau DL, Hudson EK, Hansford RG, Bohr VA. Ageassociated increase in 8-oxo-deoxyguanosine glycosylase/AP lyase activity in rat mitochondria. Nucleic Acids Res. 27: 1935-1942 (1999).
58. Kang D, Nishida J, Iyama A, Nakabeppu Y, Furuichi M, Fujiwara T, Sekiguchi M, Takeshige K. Intracellular localization of 8-oxo-dGTPase in human cells, with special reference to the role of the enzyme in mitochondria. J. Biol. Chem. 270: 14659-14665.
59. Tsutsui H, Ide T, Shiomi T, Kang D, Hayashidani S, Suematsu N, Wen J, Utsumi H, Hamasaki N, Takeshita A. 8-oxo-dGTPase, which prevents oxidative stress-induced DNA damage, increases in the mitochondria from failing hearts. Circulation 104: 2883-2885 (2001).
60. Aburatani H, Hippo Y, Ishida T, Takashima R, Matsuba C, Kodama T, Takao M, Yasui A, Yamamoto K, Asano M. Cloning and characterization of mammalian 8-hydroxyguanine-specific DNA glycosylase/apurinic, apyrimidinic lyase, a functional mutM homologue. Cancer Res. 57: 2151-2156 (1997).
61. Nishioka K, Ohtsubo T, Oda H, Fujiwara T, Kang D, Sugimachi K, Nakabeppu Y. Expression and differential intracellular localization of two major forms of human 8-oxoguanine DNA glycosylase encoded by alternatively spliced OGG1 mRNA s. Mol. Biol. Cell 10: 1637-1652 (1999).
62. Takao M, Zhang QM, Yonei S, Yasui A. Differential subcellular localization of human MutY homolog (hMYH) and the functional activity of adenine: 8-oxoguanine DNA glycosylase. Nucleic Acids Res. 27: 3638-3644 (1999).
63. Ohtsubo T, Nishioka K, Imaiso Y, Iwai S, Shimokawa H, Oda H, Fujiwara T, Nakabeppu Y. Identification of human MutY homolog (hMYH) as a repair enzyme for 2-hydroxyadenine in DNA and detection of multiple forms of hMYH located in nuclei and mitochondria. Nucleic Acids Res. 28: 1355-1364 (2000).
64. Thyagarajan B, Padua RA, Campbell C. Mammalian mitochondria possess homologous DNA recombination activity. J. Biol. Chem. 271: 27536-27543 (1996).
65. LeDoux SP, Wilson GL, Beecham EJ, Stevnsner T, Wassermann K, Bohr VA. Repair of mitochondrial DNA after various types of DNA damage in Chinese hamster ovary cells. Carcinogenesis 13: 1967-1973 (1992).
66. Clayton DA, Doda JN, Friedberg EC. The absence of a pyrimidine dimer repair mechanism in mammalian mitochondria. Proc. Natl. Acad. Sci. USA 71: 2777-2781 (1974).
67. Snyderwine EG, Bohr VA. Gene- and strand-specific damage and repair in Chinese hamster ovary cells treated with 4-nitroquinoline 1-oxide. Cancer Res. 52: 4183-4189 (1992).
68. Sancar A. DNA excision repair. Annu. Rev. Biochem. 65: 43-81 (1996).
69. Melov S, Doctrow SR, Schneider JA, Haberson J, Patel M, Coskun PE, Huffman K, Wallace DC, Malfroy B. Lifespan extension and rescue of spongiform encephalopathy in superoxide dismutase 2 nullizygous mice treated with superoxide dismutase-catalase mimetics. J. Neurosci. 21: 8348-8353 (2001).
70. Doctrow SR, Huffman K, Marcus CB, Musleh W, Bruce A, Baudry M, Malfroy B. Salen-manganese complexes: combined superoxide dismutase/catalase mimics with broad pharmacological efficacy. Adv. Pharmacol. 38: 247-269 (1997).
71. Jung C, Rong Y, Doctrow S, Baudry M, Malfroy B, Xu Z. Synthetic superoxide dismutase/catalasemimetics reduce oxidative stress and prolong survival in a mouse amyotrophic lateral sclerosis model. Neurosci. Lett. 304: 157-160 (2001).
72. Malfroy B, Doctrow SR, Orr PL, Tocco G, Fedoseyeva EV, Benichou G. Prevention and suppression of autoimmune encephalomyelitis by EUK-8, a synthetic catalytic scavenger of oxygen-reactive metabolites. Cell Immunol. 177: 62-68 (1997).
73. Melov S, Schneider JA, Day BJ, Hinerfeld Rong Y, Doctrow SR, Tocco G, Baudry M. EUK-134, a synthetic superoxide dismutase and catalase mimetic, prevents oxidative stress and attenuates kainate-induced neuropathology. Proc. Natl. Acad. Sci. USA 96: 9897-9902 (1999).
74. Ernster L, Dallner G. Biochemical, physiological and medical aspects of ubiquinone function. Biochim. Biophys. Acta 1271: 195-204 (1995).
75. 10. Neurology 38: 892-899 (1988).
76. 10 in a patient with mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes syndrome and diabetes mellitus. Eur. Neurol. 43: 54-55 (2000).
77. Mashima Y, Kigasawa K, Wakakura M, Oguchi Y. Do idebenone and vitamin therapy shorten the time to achieve visual recovery in Leber hereditary optic neuropathy? J. Neuroophthalmol. 20: 166-170 (2000).
78. Rötig A, de Lonlay P, Chretien D, Foury F, Koenig M, Sidi D, Munnich A, Rustin P. Frataxin expansion causes aconitase and mitochondrial iron-sulfur protein deficiency in Friedreich ataxia. Nat. Genet. 17: 215-217 (1997).
79. Huynen MA, Snel B, Bork P, Gibson TJ. The phylogenetic distribution of frataxin indicates a role in iron-sulfur cluster protein assembly. Hum. Mol. Genet. 10: 2463-2468 (2001).
80. Piemonte F, Pastore A, Tozzi G, Tagliacozzi D, Santorelli FM, Carrozzo R, Casali C, Damiano M, Federici G, Bertini E. Glutathione in blood of patients with Friedreich ataxia. Eur. J. Clin. Invest. 31: 1007-1011 (2001).
81. Schulz JB, Dehmer T, Schols L, Mende H, Hardt C, Vorgerd M, Burk K, Matson W, Dichgans J, Beal MF, Bogdanov MB. Oxidative stress in patients with Friedreich ataxia. Neurology 55: 1719-1721 (2000).
82. Rustin P, Rötig A, Munnich A, Sidi D. Heart hypertrophy and function are improved by idebenone in Friedreich’s ataxia. Free Radic. Res. 36: 467-470 (2002).
83. Liu CY, Lee CF, Hong CH, Wei YH. Mitochondrial DNA mutation and depletion increase the susceptibility of human cells to apoptosis. Ann. N.Y. Acad. Sci. 1011: 133-145 (2004).